Prime Medicine, Inc.
PRME- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001894562
No open-market purchases or sales by Prime Medicine, Inc. insiders were filed in the last 90 days; 187 institutions reported holding it in 13F filings for Q2 2026, worth $393.5M in total; ARK Invest is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Prime Medicine, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 132 | 1 | 125 | −6 |
| Shares | 64.3M | 392.4K | 60.4M | −3.56M (−5.6%) |
| Value | $188.0M | $1.15M | $120.4M | −$66.4M (−35.6%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Prime Medicine, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 447,600 | $890.7K | 0.00% |
| Nuveen, LLC | 59,402 | $373.7K | 0.00% |
| Palumbo Wealth Management LLC | 95,462 | $190.0K | 0.06% |
| Tudor Investment Corp Et Al | 60,368 | $120.1K | 0.00% |
| Virtus Investment Advisers, Inc. | 54,535 | $108.5K | 0.03% |
| Jacobs Levy Equity Management, Inc | 50,514 | $100.5K | 0.00% |
| Ieq Capital, LLC | 34,882 | $69.4K | 0.00% |
| Cerity Partners LLC | 31,387 | $62.5K | 0.00% |
| Brevan Howard Capital Management LP | 28,478 | $56.7K | 0.00% |
| Quadrature Capital Ltd | 24,802 | $49.6K | 0.00% |
| Sanctuary Advisors, LLC | 23,822 | $47.4K | 0.00% |
| CIBC World Markets Corp | 12,585 | $25.0K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 12,230 | $24.3K | 0.00% |
| Leonteq Securities AG | 915 | $1.82K | 0.00% |
| Rise Advisors, LLC | 575 | $1.14K | 0.00% |
| Prestige Wealth Management Group LLC | 434 | $864 | 0.00% |
| Hughes Financial Services, LLC | 480 | $857 | 0.00% |
| Coldstream Capital Management Inc | 283 | $564 | 0.00% |
| Larson Financial Group LLC | 200 | $398 | 0.00% |
| Parallel Advisors, LLC | 110 | $219 | 0.00% |
| True Wealth Design, LLC | 50 | $100 | 0.00% |
| Cordant, Inc. | 33 | $66 | 0.00% |
| Avion Wealth | 178 | $0 | 0.00% |
Sold out (29)
Institutions that held Prime Medicine, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (1)
Institutions that held Prime Medicine, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 392,443 | $1.15M |